Hledání v detailu akcií
Moje portfolio
Nastavit Oblíbené, nastavit Portfolio
Oblíbené tituly
select
NázevNejlepší
nákup
Nejlepší
prodej
Změna
(%)
ČEZ13350,00
KB-1,38
PKN155,4155,461,32
Msft522,66522,76-1,33
Nokia9,0429,044-4,62
IBM227,02227,072,96
Mercedes-Benz Group AG39,08539,18-2,02
PFE27,8327,84-0,61
08.10.2026 21:46:36
Indexy online
AD Index online
select
AD Index online
 

  • 08.10.2026 21:46:54
Tyson Foods (TSN, NY Consolidated)
Poslední obchod Změna (%) Změna (USD) Objem obchodů (USD)
52,39 1,33 0,69 59 491 830
R - Real-Time data si mohou aktivovat klienti Patria Plus / Investor Plus ZDE.

 
  • Poslední aktualizace: 08.10.2026
Popis společnosti

Business Summary: Tyson Foods, Inc. is a food company. The Company has a portfolio of products and brands, including Tyson, Jimmy Dean, Hillshire Farm, Ball Park, Wright, State Fair, Aidells and ibp. Its segments include Beef, Pork, Chicken, and Prepared Foods. The Beef segment includes operations related to processing live-fed cattle and fabricating dressed beef carcasses into primal and sub-primal meat cuts and case-ready products. The Pork segment includes operations related to processing live market hogs and fabricating pork carcasses into primal and sub-primal cuts and case-ready products. The Chicken segment includes domestic operations related to raising and processing live chickens, and purchasing raw materials for fresh, frozen and value-added chicken products and sales of specialty products. The Prepared Foods segment includes operations related to manufacturing and marketing frozen and refrigerated food products and logistics operations to move products through the supply chain.
Financial Summary: BRIEF: For the 39 weeks ended 27 June 2026, Tyson Foods Inc revenues increased 4% to $42.08B. Net income increased 23% to $527M. Revenues reflect Pork segment increase of 9% to $4.77B, Prepared Foods segment increase of 5% to $7.74B, Chicken segment increase of 3% to $12.75B. Net income benefited from Chicken segment income increase of 37% to $1.34B, Pork segment income totaling $151M vs. loss of $100M.



  • Poslední aktualizace: 08.10.2026
Management společnosti
FunkceJménoVěkVe funkci odVe firmě od
Chief Executive Officer, Co-Founder, DirectorAndre Choulika6101.01.2000
Deputy Chief Executive Officer, Co-Founder, Executive Vice President - CMC and Manufacturing, DirectorDavid Sourdive5901.01.2008
Chief Financial Officer and Chief Business OfficerArthur Stril37
Chief Human Resources Officer, Executive Vice PresidentKyung Nam-Wortman5616.11.2020
Senior Vice President - US ManufacturingSteven Doares6621.07.2020
Chief Scientific OfficerPhilippe Duchateau6301.01.2004
Chief Regulatory and Pharmaceutical Compliance OfficerStephan Reynier56
General CounselMarie-Bleuenn Terrier4401.01.2013
Chief Medical OfficerAdrian Kilcoyne5607.08.202407.08.2024